Overview of Management of Myocardial Ischemia: a Mechanistic-Based Approach

Abstract

Pharmacologic treatment of myocardial ischemia in patients with chronic stable angina (CSA) is mainly based on heart rate lowering drugs and vasodilator agents. Other drugs are available, however, that act by some peculiar mechanism (ranolazine, trimetazidine) and may add potential anti-ischemic and anti-anginal effects to standard therapeutic mechanisms… (More)
DOI: 10.1007/s10557-016-6662-5

Topics

  • Presentations referencing similar topics